BamSEC and AlphaSense Join Forces
Learn More

Rein Therapeutics Inc. – Indentures

NASDAQ: RNTX    
Share price (6/2/26): $1.03    
Market cap (6/2/26): $88.1 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 3 pages Unsecured Promissory Note
12/34/56
EX-4.10
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.9
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.8
from S-3 61 pages Rein Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.7
from S-3 59 pages Rein Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 14 pages Rein Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 16 pages Common Stock Purchase Warrant Aileron Therapeutics, Inc
12/34/56
EX-4.2
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Exchange Act of 1934, as Amended
12/34/56
EX-4.1
from 8-K 22 pages Aileron Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.8
from S-3 7 pages Form of Subordinated Note
12/34/56
EX-4.7
from S-3 6 pages Form of Senior Note
12/34/56
EX-4.6
from S-3 45 pages Aileron Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 42 pages Aileron Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.3
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Exchange Act of 1934, as Amended
12/34/56
EX-4.5
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.4
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.3
from S-3 60 pages Aileron Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.2
from S-3 57 pages Aileron Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 23 pages Seventh Amended and Restated Investor Rights Agreement
12/34/56